These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7820104)

  • 21. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
    Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
    Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of 4-acylaminophenol derivatives (T-0799 and T-0757), novel lipoxygenase inhibitors, on arachidonic acid-induced infiltration of polymorphonuclear leukocytes in rat skin.
    Kikuchi M; Ishikawa S; Tsuzurahara K
    Jpn J Pharmacol; 1994 Nov; 66(3):363-8. PubMed ID: 7869623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
    J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
    Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL
    Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methylated 2-aryl-1,4-naphtoquinone derivatives with diminished antioxidative activity].
    Wurm G; Schwandt S
    Pharmazie; 2003 Aug; 58(8):531-8. PubMed ID: 12967027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chiral dioxolane inhibitors of leukotriene biosynthesis: structure-activity relationships and syntheses using asymmetric dihydroxylation.
    Crawley GC; Briggs MT
    J Med Chem; 1995 Sep; 38(20):3951-6. PubMed ID: 7562928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
    Shizawa T; Ohmori S; Maeda K; Sakata K; Ishii T; Kamitani T
    Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biochemical evaluation of benzyl propargyl ethers as inhibitors of 5-lipoxygenase.
    Barhate NB; Reddy MC; Reddy PS; Wakharkar RD; Reddanna P
    Indian J Biochem Biophys; 2002 Aug; 39(4):264-73. PubMed ID: 22908417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
    Deigner HP; Wolf G; Ohlenmacher U; Reichling J
    Arzneimittelforschung; 1994 Aug; 44(8):956-61. PubMed ID: 7945541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenase.
    Lau CK; Bélanger PC; Dufresne C; Scheigetz J; Therien M; Fitzsimmons B; Young RN; Ford-Hutchinson AW; Riendeau D; Denis D
    J Med Chem; 1992 Apr; 35(7):1299-318. PubMed ID: 1313879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Denis D; Riendeau D
    Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
    Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
    Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
    Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil.
    Jacobson PB; Jacobs RS
    J Pharmacol Exp Ther; 1992 Aug; 262(2):874-82. PubMed ID: 1323665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril inhibits neutrophil synthesis of leukotriene B4 in vitro and in vivo.
    Shindo K; Baker JR; Munafo DA; Bigby TD
    J Immunol; 1994 Dec; 153(12):5750-9. PubMed ID: 7989772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of in vitro leukotriene B4 biosynthesis in human neutrophil granulocytes and docking studies of natural quinones.
    Landa P; Kutil Z; Temml V; Malik J; Kokoska L; Widowitz U; Pribylova M; Dvorakova M; Marsik P; Schuster D; Bauer R; Vanek T
    Nat Prod Commun; 2013 Jan; 8(1):105-8. PubMed ID: 23472470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.